These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6144166)
41. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Lee AJ; Wang JJ; Kifley A; Mitchell P Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396 [TBL] [Abstract][Full Text] [Related]
42. [The results of treating aphakic glaucoma with beta-blockers]. Kartasheva EA; Pimneva IV Vestn Oftalmol; 1999; 115(5):32-3. PubMed ID: 10582020 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830 [TBL] [Abstract][Full Text] [Related]
44. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans. Gandolfi SA; Vecchi M Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970 [TBL] [Abstract][Full Text] [Related]
45. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma]. Erichev VP; Iakubova LV Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629 [TBL] [Abstract][Full Text] [Related]
46. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95]. Nygaard HA; Høvding G Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677 [TBL] [Abstract][Full Text] [Related]
47. [A differentiated approach to the treatment of normal-pressure glaucoma]. Grigor'eva EG Vestn Oftalmol; 2003; 119(5):14-6. PubMed ID: 14598486 [TBL] [Abstract][Full Text] [Related]
49. Current use of ophthalmic beta blockers. Gross RL; Pineyro A J Glaucoma; 1997 Jun; 6(3):188-91. PubMed ID: 9211143 [No Abstract] [Full Text] [Related]
50. [Unusual indications for beta-blockers]. Hugues FC; Munera Y; Le Jeunne C Therapie; 1985; 40(6):417-21. PubMed ID: 2868538 [No Abstract] [Full Text] [Related]
51. [Adrenergic beta receptor blocking drugs in ophthalmology]. Cristea E Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1979; 23(3):219-21. PubMed ID: 43561 [No Abstract] [Full Text] [Related]
52. Clinical evidence for neuroprotection in glaucoma. Cordeiro MF; Levin LA Am J Ophthalmol; 2011 Nov; 152(5):715-6. PubMed ID: 22017839 [No Abstract] [Full Text] [Related]
53. Letter: Beta-blockers in the treatment of chronic simple glaucoma. Phillips CI Br Med J; 1976 Mar; 1(6009):584. PubMed ID: 4192 [No Abstract] [Full Text] [Related]
54. What's new for the medical therapy of glaucoma? Zimmerman TJ Ann Ophthalmol; 1978 Apr; 10(5):627-8. PubMed ID: 28060 [No Abstract] [Full Text] [Related]
58. [Beta-receptor blockers in ophthalmology]. Demmler N Med Monatsschr Pharm; 1980 Jun; 3(6):174-9. PubMed ID: 6110166 [No Abstract] [Full Text] [Related]
59. Towards integrated care: Australia's new model of care for patients with glaucoma. Lu CY; Lu VH; Goldberg I; Day RO Med J Aust; 2010 Aug; 193(4):200-1. PubMed ID: 20712538 [TBL] [Abstract][Full Text] [Related]
60. Effect on airways of beta-blockers for glaucoma. Mehta A Lancet; 1995 Sep; 346(8977):770-1. PubMed ID: 7658886 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]